Management of Intracerebral Hemorrhage With Aminocaproic Acid - Pilot Study "MANICHAN-PILOT"

Withdrawn

Phase 1 Results N/A

Summary of Purpose

This is single-arm, open-label, safety and feasibility pilot study of ɛ-aminocaproic acid in ICH patients. Consecutive ICH volume with hematoma volume less than 30 mL by ABC/2 method presenting within 3 hours of symptom onset, meeting all inclusion criteria, and without exclusions will be consented and enrolled.... Trial Stopped: Study was withdrawn from IRB review on 03/08/16

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 5 July 2017.

1 Jun 2016 18 Dec 2015 1 Jul 2017 1 Dec 2017 1 Jul 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment

Contacts

  • Reza Behrouz, DO